PURPOSE: The purpose of this study was to describe the long-term results of AlphaCor implantations, and to evaluate the main complications and risk factors. METHODS: Retrospective analysis of preoperative and follow-up data from 15 AlphaCor implantations. Analysis of outcomes, trends, and associations was performed and compared with data from published clinical trials and a literature review. RESULTS: The survival rate of the device at 1, 2, and 3 years was 87%, 58%, and 42%, respectively. Postoperative visual acuity ranged from hand movement to 0.8. The most significant complications were stromal melt (nine cases), optic deposition (three eyes), and retroprosthetic membrane formation (three eyes). The most common device-unrelated complication was trauma (three patients). All complications were managed without loss of the eye. CONCLUSION: AlphaCor provides a treatment option for patients with corneal blindness in which a donor tissue graft would not succeed.

Department of Ophthalmology University Hospital Hradec Králové Czech Republic

See more in PubMed

Hicks CR, Crawford GJ. Indications and technique: AlphaCor artificial cornea. Tech Ophthalmol. 2003;1:151–155.

Hicks CR, Crawford GJ, Dart JK, Grabner G, Holland EJ, Stulting RD, et al. AlphaCor clinical outcomes. Cornea. 2006;25:1034–1042. PubMed

Chirila TV, Vijayasekaran S, Horne R, Chen YC, Dalton PD, Constable IJ, et al. Interpenetrating polymer network (IPN) as a permanent joint between the elements of a new type of artificial cornea. J Biomed Mater Res. 1994;28:745–753. PubMed

Hicks CR, Crawford GJ, Tan DT, Snibson GR, Sutton GL, Downie N, et al. AlphaCor cases: comparative outcomes. Cornea. 2003;22:583–590. PubMed

Chirila TV, Thompson-Wallis DE, Crawford GJ, Constable IJ, Vijayasekaran S. Production of neocollagen by cells invading hydrogel sponges implanted in the rabbit cornea. Graefes Arch Clin Exp Ophthalmol. 1996;234:193–198. PubMed

Crawford GJ, Constable IJ, Chirila TV, Vijayasekaran S, Thompson DE. Tissue interaction with hydrogel sponges implanted in the rabbit cornea. Cornea. 1993;12:348–357. PubMed

Crawford GJ, Chirila TV, Vijayasekaran S, Dalton PD, Constable IJ. Preliminary evaluation of a hydrogel core-and-skirt keratoprosthesis in the rabbit cornea. J Refract Surg. 1996;12:525–529. PubMed

Fitton JH, Ziegelaar BW, Hicks CR, Clayton AB, Crawford GJ, Constable IJ, et al. Assessment of anticollagenase treatments after insertion of a keratoprosthetic material in the rabbit cornea. Cornea. 1998;17:108–114. PubMed

Hicks CR, Chirila TV, Clayton AB, Fitton JH, Vijayasekaran S, Dalton PD, et al. Clinical results of implantation of the Chirila keratoprosthesis in rabbits. Br J Ophthalmol. 1998;82:18–25. PubMed PMC

Hicks CR, Chirila TV, Dalton PD, Clayton AB, Vijayasekaran S, Crawford GJ, et al. Keratoprosthesis: preliminary results of an artificial corneal button as a full-thickness implant in the rabbit model. Aust NZ J Ophthalmol. 1996;24:297–303. PubMed

Hicks CR, Fitton JH, Chirila TV, Crawford GJ, Constable IJ. Keratoprostheses: advancing toward a true artificial cornea. Surv Ophthalmol. 1997;42:175–189. PubMed

Hicks CR, Lou X, Platten S, Clayton AB, Vijayasekaran S, Fitton HJ, et al. Keratoprosthesis results in animals: an update. Aust NZ J Ophthalmol. 1997;25 (Suppl 1:S50–S52. PubMed

Hicks CR, Vijayasekaran S, Chirila TV, Platten ST, Crawford GJ, Constable IJ. Implantation of PHEMA keratoprostheses after alkali burns in rabbit eyes. Cornea. 1998;17:301–308. PubMed

Vijayasekaran S, Fitton JH, Hicks CR, Chirila TV, Crawford GJ, Constable IJ. Cell viability and inflammatory response in hydrogel sponges implanted in the rabbit cornea. Biomaterials. 1998;19:2255–2267. PubMed

Vijayasekaran S, Hicks CR, Chirila TV, Fitton JH, Clayton AB, Lou X, et al. Histologic evaluation during healing of hydrogel core-and-skirt keratoprostheses in the rabbit eye. Cornea. 1997;16:352–359. PubMed

Ziegelaar B, Fitton JH, Clayton AB, Platten ST, Steer J, Chirila TV. The modulation of cellular responses to poly(2-hydroxyethyl methacrylate) hydrogel surfaces: phosphorylation decreases macrophage collagenase production in vitro. J Biomater Sci Polym Ed. 1998;9:849–862. PubMed

Lou X, Vijayasekaran S, Chirila TV, Maley MA, Hicks CR, Constable IJ. Synthesis, physical characterization, and biological performance of sequential homointerpenetrating polymer network sponges based on poly(2-hydroxyethyl methacrylate) J Biomed Mater Res. 1999;47:404–411. PubMed

Hicks C, Crawford G, Chirila T, Wiffen S, Vijayasekaran S, Lou X, et al. Development and clinical assessment of an artificial cornea. Prog Ret Eye Res. 2000;19:149–170. PubMed

Hicks CR, Werner L, Vijayasekaran S, Mamalis N, Apple DJ. Histology of AlphaCor skirts: evaluation of biointegration. Cornea. 2005;24:933–940. PubMed

Hicks CR, MaeVie O, Crawford GJ, Constable IJ. A risk score as part of an evidence-based approach to the selection of corneal replacement surgery. Cornea. 2005;24:523–530. PubMed

Hicks CR, Crawford GJ. Melting after keratoprosthesis implantation: the effects of medroxyprogesterone. Cornea. 2003;22:497–500. PubMed

Hicks CR, Crawford GJ, Tan DT, Snibson GR, Sutton GL, Gondhowiardjo TD, et al. Outcomes of implantation of an artificial cornea. AlphaCor: effects of prior ocular herpes simplex infection. Cornea. 2002;21:685–690. PubMed

Hicks CR, Chirila TV, Werner L, Crawford GJ, Apple DJ, Constable IJ. Deposits in artificial corneas: risk factors and prevention. Clin Experiment Ophthalmol. 2004;32:185–191. PubMed

Chirila TV, Morrison DA, Hicks CR, Gridneva Z, Barry CJ, Vijayasekaran S. In vitro drug-induced spoliation of a keratoprosthetic hydrogel. Cornea. 2004;23:620–629. PubMed

Hicks CR, Hamilton S. Retroprosthetic membranes in AlphaCor patients: risk factors and prevention. Cornea. 2005;24:692–698. PubMed

Crawford GJ, Eguchi H, Hicks CR. Two cases of AlphaCor surgery performed using a small incision technique. Clin Experiment Ophthalmol. 2005;33:10–15. PubMed

Eguchi H, Hicks CR, Crawford GJ, Tan DT, Sutton GR. Cataract surgery with AlphaCor. J Cataract Refract Surg. 2004;30:1486–1491. PubMed

Netland PA, Terada H, Dohlman CH. Glaucoma associated with keratoprosthesis. Ophthalmology. 1998;105:751–757. PubMed

Nouri M, Terada H, Alfonso EH, Foster CS, Durand ML, Dohlman CH. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119:484–489. PubMed

Coassin M, Zhang C, Gree WR, Aquavella JV, Akpek EK. Histopathologic and immunologic aspects of AlphaCor artificial corneal failure. Am J Ophthalmol. 2007;144:699–704. PubMed

Zerbe BR, Belin MW, Ciolino JB. Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113:1779–1784. PubMed

Bradle JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: The University of California Davis Experience. Cornea. 2009;28:321–327. PubMed

Chew HF, Ayres DB, Hammersmith KM, Rapuano CJ, Laibson PR, Myers JS, et al. Boston keratoprostesis outcomes and complications. Cornea. 2009;28:989–996. PubMed

Liu C, Paul B, Tandon R, Lee E, Fong K, Mavrikakis I, et al. The Osteo-Odonto-Keratoprosthesis (OOKP) Semin Ophthalmol. 2005;20:113–128. PubMed

Falcinelli G, Falsini B, Taloni M, Colliardo P, Falcinelli G. Modified osteo-odonto-keratoprosthesis for treatment of corneal blindness: long term anatomical and functional outcomes in 181 cases. Arch Ophthalmol. 2005;123:1319–51329. PubMed

Tan DTH, Tay ABG, Theng JTS, Lye KW, Parthasarathy A, Por YM, et al. Keratoprosthesis surgery for end-stage corneal blindness in Asian eyes. Ophthalmology. 2008;3:503–510. PubMed

Pineda R, Shiuey Y. The keraklear artificial cornea, a novel keratoptosthesis. Tech Ophthalmlol. 2009;7:101–104.